A recent appeals court decision could end up costing Gilead Sciences enormous sums and encourage more whistleblower lawsuits against pharma companies for poor manufacturing practices.
from Forbes Real Time https://www.forbes.com/sites/erikakelton/2017/09/26/revival-of-gilead-whistleblowers-lawsuit-should-stoke-fear-in-big-pharma/
via IFTTT
No comments:
Post a Comment